Skip to Main Content

1.2.2: Develop and implement individualized treatment plans, taking into consideration purported uses and indications for dietary supplements and complementary and alternative medicine

A patient asks you if you could recommend a dietary supplement that has been proven effective in decreasing the risk of breast cancer. What should you tell her?

(A) You explain that vitamin A 100 IU daily has been proven effective to decrease the risk of breast cancer.

(B) You explain that vitamin D 200 mg daily has been proven effective to decrease the risk of breast cancer.

(C) You explain that vitamin C 500 IU daily has been proven effective to decrease the risk of breast cancer.

(D) You explain that there are not any dietary supplements that have been proven effective in lowering the risk of breast cancer.

(E) You explain that vitamin E 100 IU daily has been proven effective to decrease the risk of breast cancer.

The Correct Answer is: D

No dietary supplement has been proven effective in reducing the risk of breast cancer (D).

Vitamin A has not been proven effective in reducing the risk of breast cancer (A). Vitamin D has not been proven effective in reducing the risk of breast cancer (B). Vitamin C has not been proven effective in reducing the risk of breast cancer (C). Vitamin E has not been proven effective in reducing the risk of breast cancer (E).

Topic: Breast cancer

A 61-year-old woman comes into your pharmacy to pick up her prescription for hydrochlorothiazide for hypertension. She asks you about taking vitamin supplements to decrease her risk of lung cancer. Her social history is significant for smoking a pack of cigarettes a day for 25 years, but she stopped a year ago. Based upon this information, you should recommend which of the following?

(A) No supplement is recommended

(B) ?-Carotene

(C) Vitamin E plus ?-carotene

(D) ?-Carotene plus retinyl palmitate

The Correct Answer is: A

To date, randomized trials of chemopreventive agents (e.g., vitamin E, ?-carotene, and retinyl palmitate) have not demonstrated any benefit in preventing lung cancer in patients at high risk for developing lung cancer (A). In two randomized clinical trials, ?-carotene has been associated with an increased risk of lung cancer and mortality in patients at high risk for developing lung cancer.

In two randomized, clinical trials, ?-carotene (B) has been associated with an increased risk of lung cancer and mortality in patients at high risk for developing lung cancer. In ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.